Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103704694 | 10370469 | 4 | F | 20130927 | 20160622 | 20140808 | 20160701 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201408000524 | ELI LILLY AND CO | 68.71 | YR | F | Y | 0.00000 | 20160701 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103704694 | 10370469 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | 620 | MG | Y | 21427 | 20 | MG | CAPSULE | QD | |||
| 103704694 | 10370469 | 2 | I | WARFARIN | WARFARIN | 1 | Oral | 2.5 MG, QD | Y | N | 0 | 2.5 | MG | TABLET | QD | ||||
| 103704694 | 10370469 | 3 | I | WARFARIN | WARFARIN | 1 | Oral | 2.5 MG, QD | Y | N | 0 | 2.5 | MG | TABLET | QD | ||||
| 103704694 | 10370469 | 4 | C | DESYREL | TRAZODONE HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | TABLET | QD | ||||||
| 103704694 | 10370469 | 5 | C | CONSTAN /00595201/ | ALPRAZOLAM | 1 | Oral | 0.4 MG, QD | 0 | .4 | MG | TABLET | QD | ||||||
| 103704694 | 10370469 | 6 | C | LYRICA | PREGABALIN | 1 | Oral | 75 MG, BID | 0 | 75 | MG | CAPSULE | BID | ||||||
| 103704694 | 10370469 | 7 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103704694 | 10370469 | 1 | Post herpetic neuralgia |
| 103704694 | 10370469 | 2 | Atrial fibrillation |
| 103704694 | 10370469 | 4 | Post herpetic neuralgia |
| 103704694 | 10370469 | 5 | Post herpetic neuralgia |
| 103704694 | 10370469 | 6 | Post herpetic neuralgia |
| 103704694 | 10370469 | 7 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103704694 | 10370469 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103704694 | 10370469 | Drug interaction | |
| 103704694 | 10370469 | Haemorrhage subcutaneous | |
| 103704694 | 10370469 | International normalised ratio increased | |
| 103704694 | 10370469 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103704694 | 10370469 | 1 | 20130927 | 20131115 | 0 | |
| 103704694 | 10370469 | 2 | 2010 | 2013 | 0 | |
| 103704694 | 10370469 | 3 | 201310 | 0 | ||
| 103704694 | 10370469 | 4 | 20130927 | 0 | ||
| 103704694 | 10370469 | 5 | 20130927 | 0 | ||
| 103704694 | 10370469 | 6 | 20131008 | 0 |